Saturday, July 16, 2011

Kiran Mazumdar Shaw


Kiran Mazumdar Shaw is the Chairman & Managing Director of Biocon Ltd, India's biggest biotechnology company. In 2004, she became India's richest woman. Kiran Mazumdar Shaw was born on March 23, 1953 in Bangalore.

Education:

She had done her schooling at Bishop Cotton Girls School and Mount Carmel College at Bangalore. After doing completing her B.Sc. in Zoology from Bangalore University in 1973, she went to Ballarat University in Melbourne, Australia and qualified as a master brewer. 

Career:

Kiran Mazumdar Shaw begin with her professional career as the trainee in brewer in Carlton & United Beverages in 1974. In  the year 1978, she joined as Trainee Manager with Biocon Biochemicals Limited in Ireland. In the same year, Kiran Mazumdar Shaw led the founded Biocon India in collaboration with Biocon Biochemicals Limited, with an initial capital of Rs.10, 000. She initially faced many problems regarding funds for her business. Banks were hesitant to give credit to her as biotechnology was a brand new field in India at that point of time and she was a woman entrepreneur, which was a rare phenomenon in the country.

Biocon’s initial operation was only to extract an enzyme from papaya. Under the guidance of Kiran Mazumdar Shaw’s stewardship Biocon transformed from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Today, Biocon is recognised as India’s pioneering biotech enterprise. In 2004, Biocon came up with an IPO and the issue was over-subscribed by over 30 times. Post-IPO, Kiran Mazumdar Shaw held close to 40% of the stock of the company and was regarded as India’s richest woman with an estimated worth of Rs. 2,100 crore.

Kiran Mazumdar Shaw is the recipient of several prestigious awards. These include ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Young’s Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Government of India also felicitated her with Padmashri (1989) and Padma Bhushan (2005).

Her business policy has created great value for the shareholders of the Biocon and under her leadership Biocon  emerged as  the  India’s best research and development company who is working on the vaccine research company has created several vaccine for the various disease like hepatitis-B,C, Antibiotics,antiallergic etc

Reward and recognition:

Kiran Mazumdar Shaw is the recipient of several prestigious awards. These include ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Young's Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Government of India also felicitated her with Padmashri (1989) and Padma Bhushan (2005).

Leadership style of the Kiran Mazumdas Shaw: 

Kiran Mazumdar Shaw inspires her team with a shared vision of the future. Transformed them into, and efficient workforce, she don’t necessarily lead from the front, as she loves t to delegate responsibility amongst their teams. While their enthusiasm is often infectious, they can need to be supported by “people”.

In Biocon, both transactional and transformational leadership has been seen. The transactional leaders (or managers) ensure that routine work is done reliably, while the transformational leaders look after initiatives that add value. High regulating and low nurturing has seen as the key factor of her behavior, she always defines the role of the group members telling them what task to do and how and when and where to do them. She is the master of her field so she has developed her trade like that. 

She always initiates the problem solving and decision making are solely by her even the solution and decision are announced by her and its implementations are closely supervised   by her. The above behavior keeps her under the authoritative and directive leadership trade. Kiran Mazumdar Shaw is known as her authority under her leadership Biocon has immerged as the most admired company in biotechnology for their research work and wealth creation. She is the great believer in herself and always led the research project under her umbrella.


No comments: